Spending time with family is what cancer patients would most value if new treatments allowed them to live for longer, a new YouGov poll reveals.

Members of the ICR’s Discovery Club saw first-hand the delicacy and complexity of techniques used to sculpt new drug molecules, as they learned how our scientists design the cancer drugs of the future.

Despite increasing numbers of cancer drugs being licensed, an analysis has found that highly innovative drugs took longer to reach NHS patients than more conventional treatments.